Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by in Pharma R&D

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. Continue reading “Harnessing big data — it’s challenging, but it can be done” »

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by in Pharma R&D

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

When drugs collide ….

Posted on July 15th, 2016 by in Pharmacovigilance

Pharmaceutical companies increasingly are adopting “proactive pharmacovigilance” and other strategies to help ensure the safety of a new entity as early as possible in the discovery/development process. Continue reading “When drugs collide ….” »

The Changing Competencies of Pharmacovigilance Leadership

Posted on June 27th, 2016 by in Pharmacovigilance

Significant transformations happened over the last decade regarding the role of pharmacovigilance (PV) departments in pharmaceutical organizations. This had a tremendous impact not only on the technical knowledge needed, but more importantly on the non-technical competencies that should be required for any PV role in pharma. Continue reading “The Changing Competencies of Pharmacovigilance Leadership” »